AstraZeneca buys Novo Holdings portfolio company Amolyt in potential $1bn+ deal Novo Holdings A/S and Sofinnova Partners, two leading life sciences investors, made headlines on Thursday when portfolio company Amolyt Pharma entered into a definitive agreement to be acquired by AstraZeneca at a purchase price of US$800 million upfront and a potential milestone payment of […]
Deal value up to US$1.05 billion Novo Holdings co-led Series A financing in Amolyt, supported additional financings and is Amolyt’s largest investor Acquisition validates Novo Holdings’ strategy to identify and invest long term in high quality European biotech companies Copenhagen, Denmark – Novo Holdings A/S, a leading international life sciences investor, today announced that its portfolio […]
In April 2020 Kate Bingham was invited by Sir Patrick Vallance, the government’s chief scientific advisor, to join the Vaccine Expert Advisory Group. In May 2020 she was appointed Chair of the UK Vaccine Taskforce (VTF), an idea originated by Patrick Vallance, reporting to the Prime Minister to lead UK efforts to find and manufacture […]
